August 14, 2024

Today’s guest on The Long Run is Sarah Boyce. She is the CEO of San Diego-based Avidity Biosciences. Avidity is a developer of RNA medicines. It uses what it calls “antibody oligonucleotide conjugates”. These are molecules that connect an antibody — which hits a specific target on the surface of cells – with an RNA-silencing molecule. That RNA molecule can... Read More